No Data
No Data
H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $73
The stock price has dropped nearly 30% in three months. What is left of the legendary biotech (LEGN.US) that called off the sale?
Affected by the "acquisition storm", the stock price of legend biotech reached a high of $60.87 on July 26 and has been in a fluctuating downtrend. By the closing price on October 16, it had fallen to $44.02, a decrease of 27.68% from the peak.
Scotiabank Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $76
A Quick Look at Today's Ratings for Legend Biotech(LEGN.US), With a Forecast Between $73 to $94
9 Analysts Have This To Say About Legend Biotech
Legend Biotech (LEGN) Gets a Buy From Scotiabank